| -0.09 / -1.89%|
The 6 analysts offering 12-month price forecasts for Chelsea Therapeutics International Ltd have a median target of 8.50, with a high estimate of 12.00 and a low estimate of 8.00. The median estimate represents a +82.01% increase from the last price of 4.67.
The current consensus among 6 polled investment analysts is to Buy stock in Chelsea Therapeutics International Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.